Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sharfstein Pledges FDA Spending Will Generate Public Health Value

Executive Summary

The FDA under Margaret Hamburg and Joshua Sharfstein will be a proactive, results-oriented public health agency, Sharfstein indicated to congressional appropriations panels May 21
Advertisement

Related Content

Horowitz Goes From FDA Office Of Policy To HHS Office Of General Counsel
Rx Safety: FDA Needs Deadline - Not Funding - To Improve Process, GAO Says
Rx Safety: FDA Needs Deadline - Not Funding - To Improve Process, GAO Says
FDA Appropriations In Senate: Money For Generics; Worry About Tobacco
Sharfstein Heads FDA Transparency Task Force
Hamburg/Sharfstein Agenda For FDA Emphasizes Collaboration
Sharfstein Heads FDA Transparency Task Force
Sharfstein Optimistic On Prospects For Generic Drug User Fees
Hamburg Confirmed As FDA Commissioner, Awaits Swearing In
FDA Chief Scientist Goodman Spearheads Agency Response To Swine Flu

Topics

Advertisement
UsernamePublicRestriction

Register

PS051105

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel